Nonsustained ventricular tachycardia is usually asymptomatic because of its short duration, but some patients complain about palpitations. It can be recorded at rest in asymptomatic individuals [1] and it can be a part of the “athlete's heart syndrome” [2]. In trained athletes with no structural heart disease, genetic channelopathies and early repolarization, it is considered to be benign, as it disappears during deconditioning periods [3]. However, the physician must inquire about the use of potentially proarrhythmic drugs and personal and familial history of heart disease, syncope and sudden death [4].

Longer arrhythmic episodes can cause lightheadedness and anxiety. Syncope, diaphoresis, pallor, hypotension and dyspnea are not usually encountered with nonsustained ventricular tachycardia episodes, but rather with sustained ones. Physical examination may reveal cannon a-waves if atrial fibrillation or flutter is absent and a variation of the first heart sound’s intensity on auscultation. However, these findings are only present during the acute episode, therefore the physician only finds them if he or she examines the patient during those few seconds, so the patient must have already been admitted to a hospital.

Nonsustained ventricular tachycardia patients must undergo a thorough cardiac evaluation. The most frequent causes of the disease in middle-aged individuals are myocardial ischemia, valve diseases and cardiomyopathies, whereas younger people may suffer from long QT syndrome, arrhythmogenic right ventricular cardiomyopathy or Brugada syndrome.

Blood workup should include potassium, calcium, magnesium and phosphate evaluation, as well as measurement of serum digoxin and tricyclic antidepressants levels or toxicology screening where appropriate. Cardiac troponins should also be measured when acute myocardial ischemia is suspected.

A simple electrocardiogram is able to pinpoint the approximate location of the ventricular contractions and to describe the tachycardia as monomorphic or polymorphic. The location of the R/S transition may predict the presence of arrhythmogenic right ventricular cardiomyopathy [5], whereas the duration of the cardiac cycle during the episode is an indicator of concomitant polymorphic ventricular tachycardia [6]. Holter monitoring is usually indicated in symptomatic patients and accurately describes arrhythmic episodes [7]. Further information is added by electrophysiology testing. In patients where arrhythmic episodes can be induced, the mortality risk is higher [8].

Some episodes are exercise-induced and may be caused by ventricular outflow arrhythmias [9]. Right ventricular outflow ectopic loci cause a left bundle branch block pattern, whereas those located in the left ventricle outflow tract appear as right bundle branch block complexes. Structural abnormalities of these areas can be demonstrated by magnetic resonance imaging or myocardial biopsy [10] [11].

Echocardiography is another useful tool, as it is able to describe myocardial scars (visualized as akinetic regions), left ventricular hypertrophy (an indicator of long-term hypertension) and the presence and severity of valvulopathies. Cardiomegaly also predicts nonsustained ventricular tachycardia episodes [12]. If the arrhythmia is detected during the recovery period of an exercise test, it indicates cardiovascular mortality during the next decades [13].

Treatment for NSVT depends on the underlying cause and the presence of symptoms. In asymptomatic individuals with no structural heart disease, treatment may not be necessary. For those with symptoms or underlying heart conditions, options include lifestyle modifications, medications such as beta-blockers or antiarrhythmic drugs, and in some cases, catheter ablation, a procedure that destroys the heart tissue causing the abnormal rhythm. Implantable cardioverter-defibrillators (ICDs) may be recommended for patients at high risk of life-threatening arrhythmias.

The prognosis for NSVT varies based on the underlying cause and the presence of heart disease. In individuals without structural heart disease, NSVT is often benign and does not significantly impact life expectancy. However, in patients with heart disease, NSVT can be a marker for increased risk of more serious arrhythmias and may require ongoing monitoring and treatment to prevent complications.

NSVT can result from various causes, including structural heart disease, such as coronary artery disease or cardiomyopathy, electrolyte imbalances, and certain medications. It can also occur in individuals with no apparent heart disease, often referred to as idiopathic NSVT. In these cases, the exact cause is unknown, but it is generally considered less concerning.

NSVT is relatively common, especially in older adults and those with existing heart conditions. It is often detected during routine cardiac evaluations or in patients undergoing monitoring for other heart-related issues. The prevalence of NSVT increases with age and is more frequently observed in individuals with structural heart disease.

NSVT occurs when abnormal electrical signals in the ventricles cause the heart to beat rapidly and irregularly. This can result from reentry circuits, where electrical impulses loop back on themselves, or from increased automaticity, where heart cells spontaneously generate electrical signals. These mechanisms can be influenced by structural changes in the heart, electrolyte imbalances, or other factors affecting cardiac electrical activity.

Preventing NSVT involves managing risk factors for heart disease, such as maintaining a healthy lifestyle, controlling blood pressure and cholesterol levels, and avoiding substances that can trigger arrhythmias, like excessive caffeine or alcohol. Regular medical check-ups and monitoring for those with known heart conditions can help detect and manage NSVT early.

Nonsustained Ventricular Tachycardia is a condition characterized by brief episodes of rapid heartbeats originating from the ventricles. While often benign, it can indicate underlying heart issues that require further evaluation. Diagnosis involves ECG and Holter monitoring, and treatment depends on symptoms and underlying causes. Managing risk factors and regular monitoring are key to preventing complications.

If you have been diagnosed with NSVT, it's important to understand that this condition can vary widely in its implications. For many, it may not cause any problems, but for others, especially those with heart disease, it may require treatment and regular follow-up. Discuss with your healthcare provider about the best management plan for your specific situation, including lifestyle changes and possible treatments. Regular check-ups and monitoring are essential to ensure your heart health is maintained.

1. Engstrom G, Hedblad B, Janzon L, et al. Ventricular arrhythmias during 24-h ambulatory ECG recording: incidence, risk factors and prognosis in men with and without a history of cardiovascular disease. J Intern Med.1999;246:363–72.
2. Biffi A, Maron BJ, Verdile L, et al. Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol.2004; 44:1053–8.
3. Biffi A, Maron BJ, Culasso F, et al. Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities. Am J Cardiol.2011;107:697–703.
4. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. J Am Coll Cardiol. 2006; 48(5):e247-346.
5. Hoffmayer KS, Machado ON, Marcus GM, et al. Electrocardiographic comparison of ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract tachycardia. J Am Coll Cardiol. 2011;58:831–8.
6. Shimizu W. Arrhythmias originating from the right ventricular outflow tract: how to distinguish “malignant” from “benign”? Heart Rhythm. 2009; 6:1507–11.
7. Pastor-Pérez FJ, Manzano-Fernández S, Goya-Esteban R, et al. Comparison of detection of arrhythmias in patients with chronic heart failure secondary to non-ischemic versus ischemic cardiomyopathy by 1 versus 7-day Holter monitoring. Am J Cardiol. 2010;106:677–81.
8. Buxton AE, Lee KL, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death: Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 2000;342:1937–45.
9. Kim RJ, Iwai S, Markowitz SM, et al. Clinical and electrophysiological spectrum of idiopathic ventricular outflow tract arrhythmias. J Am Coll Cardiol. 2007;49:2035–43.
10. Carlson MD, White RD, Trohman RG, et al. Right ventricular outflow tract ventricular tachycardia: detection of previously unrecognized anatomic abnormalities using cine magnetic resonance imaging. J Am Coll Cardiol. 1004;24:720–7.
11. Chimenti C, Calabrese F, Thiene G, et al. Inflammatory left ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias. Circulation. 2001;104:168–73.
12. Di Bella G, Passino C, Aquaro GD, et al. Different substrates of non-sustained ventricular tachycardia in post-infarction patients with and without left ventricular dilatation. J Card Fail. 2010;16:61–8.
13. Katritsis DG, Zareba W, Camm AJ.Nonsustained ventricular tachycardia. J Am Coll Cardiol. 2012;60(20):1993-2004.